Greenwich LifeSciences, Inc. (GLSI)
Greenwich LifeSciences Market Cap : 333.89M for Feb. 20, 2026
Market Cap Chart
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
| 60 Degrees Pharmaceuticals, Inc. | 3.952M |
| Abbott Laboratories | 195.41B |
| Bristol Myers Squibb Co. | 123.78B |
| Janux Therapeutics, Inc. | 789.74M |
| Moderna, Inc. | 19.52B |
Market Cap Related Metrics
| PEG Ratio | -0.2046 |
| Price to Book Value | 152.82 |
| Price | 24.10 |
| Earnings Yield | -6.08% |
| PEGY Ratio | -0.2046 |